GlassScriptPhysician profile
Osama Alsara
NPI 1689967705
$5,228.75
in general payments reported to CMS, 2019-2025
13 companies · $3,051 in 2025
The $3,051 reported for 2025 was more than what 96% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $273 · 2022: $171 · 2023: $1,032 · 2024: $702 · 2025: $3,051.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,752 · Food and Beverage: $1,603 · Consulting Fee: $215 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $215.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,752.37 |
| Food and Beverage | $1,602.74 |
| Consulting Fee | $214.84 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $214.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $1,645.19 | 2025 | Igt Devices Undivided, Ice 3d |
| Abbott Laboratories | $1,355.18 | 2024-2025 | Triclip, Perclose Prostyle, Mitraclip |
| Heartflow, INC. | $1,189.32 | 2023-2025 | Ffrct |
| Boston Scientific Corporation | $445.90 | 2022-2025 | Watchman Access System |
| Edwards Lifesciences Corporation | $110.05 | 2019 | |
| Biotronik INC. | $104.05 | 2022 | |
| Astellas Pharma US INC | $99.99 | 2019 | |
| Janssen Pharmaceuticals, INC | $63.47 | 2024 | Xarelto |
| Amgen INC. | $62.58 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $55.57 | 2024 | Camzyos |
| Cleerly, INC. | $48.40 | 2025 | Cleerly Labs, Cleerly Ischemia |
| Novartis Pharmaceuticals Corporation | $32.55 | 2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $16.50 | 2025 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Osama Alsara listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.